posted by AHIP
on November 16, 2020
WASHINGTON, D.C. – Every day, COVID-19 continues to put pressure on America’s health care system and the patients and communities it serves. Health insurance providers are responding to this crisis by taking decisive action to ensure that Americans have access to the diagnostic testing and treatment needed to effectively combat this virus. However, data from a new survey conducted by America’s Health Insurance Plans (AHIP) shows that out-of-network COVID-19 test costs continue to rise, significantly exceeding in-network costs and ultimately jeopardizing affordability:
These findings are based on a survey of health insurance providers in the commercial market conducted by AHIP to gather data on prices charged by out-of-network providers for diagnostic, antibody, antigen tests for COVID-19. Conducted in October 2020, the enrollment-weighted survey data includes 22 responses from plans representing 76% of commercial enrollment of AHIP member plans.
AHIP conducted an initial survey of out-of-network COVID-19 testing costs in July 2020. Those results can be found here.
From ensuring access to testing, to expanding health delivery capacity, to taking action to mitigate the economic and societal impact, health insurance providers are delivering solutions to the COVID-19 crisis. Click here to view the study results and AHIP’s recommendations on how this price gouging can be stopped.
AHIP is the national association whose members provide coverage for health care and related services to hundreds of millions of Americans every day. Through these offerings, we improve and protect the health and financial security of consumers, families, businesses, communities and the nation. We are committed to market-based solutions and public-private partnerships that improve affordability, value, access, and well-being for consumers. Visit www.ahip.org for more information.